BlossomHill Therapeutics Q2 Loss Widens
MT newswire2026/09/18 11:42Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
07:42 AM EDT, 09/18/2026 (MT Newswires) -- BlossomHill Therapeutics (BLSM) reported a Q2 loss on Friday of $8.75 per share, widening from a loss of $5.51 a year earlier. One analyst polled by FactSet expected a GAAP loss of $0.77. The company did not report any revenue for the quarter. Cash and cash equivalents for the quarter ended June 30 totaled $95.4 million, which, together with proceeds from its recent IPO, should be sufficient to fund operations into Q2 2028, the company said.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
CapsoVision prices registered direct offering of 3,163,444 shares at USD 5.69 each
Bitget•2026/09/18 20:09
Hyperfine risks Nasdaq delisting after HYPR bid price stays below $1 for 30 sessions
Bitget•2026/09/18 20:08
Crypto prices
More
Bitcoin
BTC
$81,104.77
+5.94%
Ethereum
ETH
$2,634.14
+7.45%
Tether USDt
USDT
$0.9996
+0.04%
BNB
BNB
$764.29
+4.34%
XRP
XRP
$1.41
+8.55%
USDC
USDC
$0.9997
-0.01%
Solana
SOL
$113.85
+12.58%
TRON
TRX
$0.3383
+0.99%
Zcash
ZEC
$1,477.62
-1.28%
Hyperliquid
HYPE
$92.21
+10.42%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now